Baxalta

Overview

• HeadquartersBannockburn¹
• Websitewww.baxalta.com
• Legal formDelaware corporation¹
• LEI5493000JW8DCO3T45R55³
• StatusActive³
• LEI statusLapsed (not renewed)³
• Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States³
• Registered withDivision of Corporations, Department of State, 5572011³

See how the biggest companies compare on our leaderboards

Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound') is a biopharmaceutical company founded on July 1, 2015 after its parent company, Baxter International, spun off its biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company.²

Corporate structure

Baxalta sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

Products and brands

• hematology

Listed on Wikidata.¹

Acquisitions

1. Succeeded Baxter BioScience¹

Timeline

1. 2016Dissolved Dissolved¹
2. 2015Founded Founded¹

Links

• Websitewww.baxalta.com¹
• WikipediaBaxalta
• WikidataQ21970569